URINARY-EXCRETION OF VALPROATE AND SOME METABOLITES IN CHRONICALLY TREATED PATIENTS

被引：68

作者：

DICKINSON, RG ^{[1
]}

HOOPER, WD ^{[1
]}

DUNSTAN, PR ^{[1
]}

EADIE, MJ ^{[1
]}

机构：

[1] UNIV QUEENSLAND,DEPT MED,NEUROPHARMACOL & DRUG METAB LAB,BRISBANE,QLD 4000,AUSTRALIA

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 02期

关键词：

D O I：

10.1097/00007691-198903000-00002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：127 / 133

页数：7

相关论文

共 17 条

[1] THE EFFECT OF ASPIRIN ON VALPROIC ACID METABOLISM
ABBOTT, FS
KASSAM, J
ORR, JM
FARRELL, K
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (01) : 94 - 100
[2] MECHANISM OF ANTI-CONVULSANT ACTION OF VALPROATE
CHAPMAN, A
KEANE, PE
MELDRUM, BS
SIMIAND, J
VERNIERES, JC
[J]. PROGRESS IN NEUROBIOLOGY, 1982, 19 (04) : 315 - 359
[3] DICKINSON RG, 1979, J PHARMACOL EXP THER, V211, P583
[4] DICKINSON RG, 1980, J PHARMACOL EXP THER, V213, P38
[5] REARRANGEMENT OF VALPROATE GLUCURONIDE IN A PATIENT WITH DRUG-ASSOCIATED HEPATOBILIARY AND RENAL DYSFUNCTION
DICKINSON, RG
KLUCK, RM
HOOPER, WD
PATTERSON, M
CHALK, JB
EADIE, MJ
[J]. EPILEPSIA, 1985, 26 (06) : 589 - 593
[6] VALPROATE-ASSOCIATED HEPATOTOXICITY AND ITS BIOCHEMICAL-MECHANISMS
EADIE, MJ
HOOPER, WD
DICKINSON, RG
[J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1988, 3 (02): : 85 - 106
[7] IDENTIFICATION OF URINARY METABOLITES OF SODIUM DIPROPYLACETATE IN MAN - POTENTIAL SOURCES OF INTERFERENCE IN ORGANIC-ACID SCREENING PROCEDURES
GOMPERTZ, D
TIPPETT, P
BARTLETT, K
BAILLIE, T
[J]. CLINICA CHIMICA ACTA, 1977, 74 (02) : 153 - 160
[8] ASPECTS OF THE METABOLISM OF VALPROIC ACID
GRANNEMAN, GR
WANG, SI
MACHINIST, JM
KESTERSON, JW
[J]. XENOBIOTICA, 1984, 14 (05) : 375 - 387
[9] GRANNEMAN GR, 1984, METABOLISM ANTIEPILE, P97
[10] CLINICAL PHARMACOKINETICS OF VALPROIC ACID
GUGLER, R
UNRUH, GEV
[J]. CLINICAL PHARMACOKINETICS, 1980, 5 (01) : 67 - 83